Nymox Pharmaceutical
NYMX
#9947
Rank
HK$0.14 B
Marketcap
Country
HK$1.56
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -HK$17.02 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -HK$50.85 Million, an increase over its 2021 earnings that were of -HK$97.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -HK$17.02 Million-66.53%
2022 -HK$50.85 Million-47.71%
2021 -HK$97.24 Million6.61%
2020 -HK$91.21 Million-10.91%
2019 -HK$0.11 Billion24.24%
2018 -HK$82.4 Million-20.03%
2017 -HK$0.11 Billion2.71%
2016 -HK$0.11 Billion-63.86%
2015 -HK$0.28 Billion674.44%
2014 -HK$35.85 Million-6.11%
2013 -HK$38.18 Million-35.66%
2012 -HK$59.35 Million-20.76%
2011 -HK$74.9 Million38.33%
2010 -HK$54.14 Million35.59%
2009 -HK$39.93 Million11.8%
2008 -HK$35.72 Million-12.94%
2007 -HK$41.03 Million8.85%
2006 -HK$37.69 Million36.5%
2005 -HK$27.61 Million-4.4%
2004 -HK$28.89 Million-14.58%
2003 -HK$33.82 Million
2001 -HK$24.81 Million-20.54%
2000 -HK$31.22 Million21.72%
1999 -HK$25.65 Million-25.56%
1998 -HK$34.46 Million101.3%
1997 -HK$17.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$52.80 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$54.09 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.67 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.08 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.31 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA